These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7168950)

  • 21. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.
    Greber S; Lubec G; Cairns N; Fountoulakis M
    Electrophoresis; 1999; 20(4-5):928-34. PubMed ID: 10344268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau protein abnormalities associated with the progression of alzheimer disease type dementia.
    Haroutunian V; Davies P; Vianna C; Buxbaum JD; Purohit DP
    Neurobiol Aging; 2007 Jan; 28(1):1-7. PubMed ID: 16343696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance spectroscopy and its application to aging and Alzheimer's disease.
    McClure RJ; Kanfer JN; Panchalingam K; Klunk WE; Pettegrew JW
    Neuroimaging Clin N Am; 1995 Feb; 5(1):69-86. PubMed ID: 7743086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein metabolism of the aging nervous system. Structural and functional aspects.
    Scand J Clin Lab Invest Suppl; 1974; 141():13-22. PubMed ID: 4464568
    [No Abstract]   [Full Text] [Related]  

  • 26. Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies.
    Campbell BC; Li QX; Culvenor JG; Jäkälä P; Cappai R; Beyreuther K; Masters CL; McLean CA
    Neurobiol Dis; 2000 Jun; 7(3):192-200. PubMed ID: 10860784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.
    Tannenberg RK; Scott HL; Tannenberg AE; Dodd PR
    Neurochem Int; 2006 Dec; 49(7):631-9. PubMed ID: 16814428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes of neurocalcin, a calcium-binding protein, in the brain of patients with Alzheimer's disease.
    Shimohama S; Chachin M; Taniguchi T; Hidaka H; Kimura J
    Brain Res; 1996 Apr; 716(1-2):233-6. PubMed ID: 8738246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of microarray analysis.
    Loring JF
    Neurobiol Aging; 2006 Aug; 27(8):1084-6. PubMed ID: 16165253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain.
    Funato H; Yoshimura M; Yamazaki T; Saido TC; Ito Y; Yokofujita J; Okeda R; Ihara Y
    Am J Pathol; 1998 Apr; 152(4):983-92. PubMed ID: 9546359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.
    Lüth HJ; Ogunlade V; Kuhla B; Kientsch-Engel R; Stahl P; Webster J; Arendt T; Münch G
    Cereb Cortex; 2005 Feb; 15(2):211-20. PubMed ID: 15238435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.
    Yoo BC; Fountoulakis M; Cairns N; Lubec G
    Electrophoresis; 2001 Jan; 22(1):172-9. PubMed ID: 11197169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin H(2)-derived adducts of proteins correlate with Alzheimer's disease severity.
    Zagol-Ikapitte I; Masterson TS; Amarnath V; Montine TJ; Andreasson KI; Boutaud O; Oates JA
    J Neurochem; 2005 Aug; 94(4):1140-5. PubMed ID: 15992375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in trace elements during brain aging and in Alzheimer's dementia.
    Chazot G; Broussolle E
    Prog Clin Biol Res; 1993; 380():269-81. PubMed ID: 8456130
    [No Abstract]   [Full Text] [Related]  

  • 35. Lactotransferrin immunocytochemistry in Alzheimer and normal human brain.
    Kawamata T; Tooyama I; Yamada T; Walker DG; McGeer PL
    Am J Pathol; 1993 May; 142(5):1574-85. PubMed ID: 8494052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.
    Markesbery WR; Lovell MA
    Arch Neurol; 2007 Jul; 64(7):954-6. PubMed ID: 17620484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age.
    Kok E; Haikonen S; Luoto T; Huhtala H; Goebeler S; Haapasalo H; Karhunen PJ
    Ann Neurol; 2009 Jun; 65(6):650-7. PubMed ID: 19557866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer's disease.
    Ojaimi J; Masters CL; McLean C; Opeskin K; McKelvie P; Byrne E
    Ann Neurol; 1999 Oct; 46(4):656-60. PubMed ID: 10514105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early brain response to low-dose radiation exposure involves molecular networks and pathways associated with cognitive functions, advanced aging and Alzheimer's disease.
    Lowe XR; Bhattacharya S; Marchetti F; Wyrobek AJ
    Radiat Res; 2009 Jan; 171(1):53-65. PubMed ID: 19138050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Boxer's brain and other types of post-traumatic dementia].
    Tokuda T
    No To Shinkei; 1993 Dec; 45(12):1109-18. PubMed ID: 8123301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.